{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T17:15:12Z","timestamp":1790183712415,"version":"4.1.0"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T00:00:00Z","timestamp":1588636800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T00:00:00Z","timestamp":1588636800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>A new human coronavirus named SARS-CoV-2 was identified in several cases of acute respiratory syndrome in Wuhan, China in December 2019. On March 11 2020, WHO declared the SARS-CoV-2 infection to be a pandemic, based on the involvement of 169 nations. Specific drugs for SARS-CoV-2 are obviously not available. Currently, drugs originally developed for other viruses or parasites are currently in clinical trials based on empiric data. In the quest of an effective antiviral drug, the most specific target for an RNA virus is the RNA-dependent RNA-polymerase (RdRp) which shows significant differences between positive-sense and negative-sense RNA viruses. An accurate evaluation of RdRps from different viruses may guide the development of new drugs or the repositioning of already approved antiviral drugs as treatment of SARS-CoV-2. This can accelerate the containment of the SARS-CoV-2 pandemic and, hopefully, of future pandemics due to other emerging zoonotic RNA viruses.<\/jats:p>","DOI":"10.1186\/s12967-020-02355-3","type":"journal-article","created":{"date-parts":[[2020,5,5]],"date-time":"2020-05-05T18:02:55Z","timestamp":1588701775000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":71,"title":["SARS-CoV-2 RNA polymerase as target for antiviral therapy"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6380-7114","authenticated-orcid":false,"given":"Luigi","family":"Buonaguro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Tagliamonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Lina","family":"Tornesello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco M.","family":"Buonaguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,5]]},"reference":[{"key":"2355_CR1","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.ijid.2020.01.009","volume":"91","author":"DS Hui","year":"2020","unstructured":"Hui DS, Azhar I, Madani TA, Ntoumi F, Kock R, Dar O, et al. The continuing 2019-nCoV epidemic threat of novel coronaviruses to global health\u2014the latest 2019 novel coronavirus outbreak in Wuhan, China. Int J Infect Dis. 2020;91:264\u20136.","journal-title":"Int J Infect Dis"},{"key":"2355_CR2","doi-asserted-by":"publisher","first-page":"taaa011","DOI":"10.1093\/jtm\/taaa011","volume":"27","author":"II Bogoch","year":"2020","unstructured":"Bogoch II, Watts A, Thomas-Bachli A, Huber C, Kraemer MUG, Khan K. Potential for global spread of a novel coronavirus from China. J Travel Med. 2020;27:taaa011.","journal-title":"J Travel Med"},{"key":"2355_CR3","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1038\/nrmicro.2016.81","volume":"14","author":"E de Wit","year":"2016","unstructured":"de Wit E, van Doremalen N, Falzarano D, Munster VJ. SARS and MERS: recent insights into emerging coronaviruses. Nat Rev Microbiol. 2016;14:523\u201334.","journal-title":"Nat Rev Microbiol"},{"key":"2355_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1186\/s12985-015-0422-1","volume":"12","author":"B Hu","year":"2015","unstructured":"Hu B, Ge X, Wang LF, Shi Z. Bat origin of human coronaviruses. Virol J. 2015;12:221.","journal-title":"Virol J"},{"key":"2355_CR5","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1038\/nm.3985","volume":"21","author":"VD Menachery","year":"2015","unstructured":"Menachery VD, Yount BL Jr, Debbink K, Agnihothram S, Gralinski LE, Plante JA, et al. A SARS-like cluster of circulating bat coronaviruses shows potential for human emergence. Nat Med. 2015;21:1508\u201313.","journal-title":"Nat Med"},{"key":"2355_CR6","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciaa149","author":"KK To","year":"2020","unstructured":"To KK, Tsang OT, Chik-Yan YC, Chan KH, Wu TC, Chan JMC, et al. Consistent detection of 2019 novel coronavirus in saliva. Clin Infect Dis. 2020. https:\/\/doi.org\/10.1093\/cid\/ciaa149.","journal-title":"Clin Infect Dis"},{"key":"2355_CR7","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1056\/NEJMc2001468","volume":"382","author":"C Rothe","year":"2020","unstructured":"Rothe C, Schunk M, Sothmann P, Bretzel G, Froeschl G, Wallrauch C, et al. Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. N Engl J Med. 2020;382:970\u20131.","journal-title":"N Engl J Med"},{"key":"2355_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-020-2196-x","author":"R Wolfel","year":"2020","unstructured":"Wolfel R, Corman VM, Guggemos W, Seilmaier M, Zange S, Muller MA, et al. Virological assessment of hospitalized patients with COVID-2019. Nature. 2020. https:\/\/doi.org\/10.1038\/s41586-020-2196-x.","journal-title":"Nature"},{"key":"2355_CR9","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1126\/science.134.3478.556","volume":"134","author":"E Reich","year":"1961","unstructured":"Reich E, Franklin RM, Shatkin AJ, Tatum EL. Effect of actinomycin D on cellular nucleic acid synthesis and virus production. Science. 1961;134:556\u20137.","journal-title":"Science"},{"key":"2355_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3390\/v9100309","volume":"9","author":"A Harwig","year":"2017","unstructured":"Harwig A, Landick R, Berkhout B. The battle of RNA synthesis: virus versus host. Viruses. 2017;9:309.","journal-title":"Viruses"},{"key":"2355_CR11","doi-asserted-by":"publisher","first-page":"3867","DOI":"10.1002\/j.1460-2075.1989.tb08565.x","volume":"8","author":"O Poch","year":"1989","unstructured":"Poch O, Sauvaget I, Delarue M, Tordo N. Identification of four conserved motifs among the RNA-dependent polymerase encoding elements. EMBO J. 1989;8:3867\u201374.","journal-title":"EMBO J"},{"key":"2355_CR12","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.3389\/fmicb.2019.01945","volume":"10","author":"H Jia","year":"2019","unstructured":"Jia H, Gong P. A structure\u2013function diversity survey of the RNA-dependent RNA polymerases from the positive-strand RNA viruses. Front Microbiol. 2019;10:1945.","journal-title":"Front Microbiol"},{"key":"2355_CR13","doi-asserted-by":"publisher","first-page":"e0139001","DOI":"10.1371\/journal.pone.0139001","volume":"10","author":"R Jacome","year":"2015","unstructured":"Jacome R, Becerra A, de Ponce LS, Lazcano A. Structural analysis of monomeric RNA-dependent polymerases: evolutionary and therapeutic implications. PLoS ONE. 2015;10:e0139001.","journal-title":"PLoS ONE"},{"key":"2355_CR14","first-page":"137","volume":"320","author":"KK Ng","year":"2008","unstructured":"Ng KK, Arnold JJ, Cameron CE. Structure\u2013function relationships among RNA-dependent RNA polymerases. Curr Top Microbiol Immunol. 2008;320:137\u201356.","journal-title":"Curr Top Microbiol Immunol"},{"key":"2355_CR15","doi-asserted-by":"publisher","first-page":"8416","DOI":"10.1128\/JVI.71.11.8416-8428.1997","volume":"71","author":"V Lohmann","year":"1997","unstructured":"Lohmann V, Korner F, Herian U, Bartenschlager R. Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity. J Virol. 1997;71:8416\u201328.","journal-title":"J Virol"},{"key":"2355_CR16","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1128\/JVI.74.8.3888-3891.2000","volume":"74","author":"AL Vazquez","year":"2000","unstructured":"Vazquez AL, Alonso JM, Parra F. Mutation analysis of the GDD sequence motif of a calicivirus RNA-dependent RNA polymerase. J Virol. 2000;74:3888\u201391.","journal-title":"J Virol"},{"key":"2355_CR17","doi-asserted-by":"publisher","first-page":"7385","DOI":"10.1073\/pnas.0611599104","volume":"104","author":"J Pan","year":"2007","unstructured":"Pan J, Vakharia VN, Tao YJ. The structure of a birnavirus polymerase reveals a distinct active site topology. Proc Natl Acad Sci USA. 2007;104:7385\u201390.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2355_CR18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nature17180","volume":"531","author":"TK Warren","year":"2016","unstructured":"Warren TK, Jordan R, Lo MK, Ray AS, Mackman RL, Soloveva V, et al. Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys. Nature. 2016;531:381\u20135.","journal-title":"Nature"},{"key":"2355_CR19","doi-asserted-by":"publisher","first-page":"449","DOI":"10.2183\/pjab.93.027","volume":"93","author":"Y Furuta","year":"2017","unstructured":"Furuta Y, Komeno T, Nakamura T. Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase. Proc Jpn Acad Ser B Phys Biol Sci. 2017;93:449\u201363.","journal-title":"Proc Jpn Acad Ser B Phys Biol Sci"},{"key":"2355_CR20","doi-asserted-by":"publisher","first-page":"6233","DOI":"10.3390\/v7122934","volume":"7","author":"O Reynard","year":"2015","unstructured":"Reynard O, Nguyen XN, Alazard-Dany N, Barateau V, Cimarelli A, Volchkov VE. Identification of a new ribonucleoside inhibitor of Ebola virus replication. Viruses. 2015;7:6233\u201340.","journal-title":"Viruses"},{"key":"2355_CR21","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.ijantimicag.2018.12.010","volume":"53","author":"M Bourliere","year":"2019","unstructured":"Bourliere M, Pietri O. Hepatitis C virus therapy: no one will be left behind. Int J Antimicrob Agents. 2019;53:755\u201360.","journal-title":"Int J Antimicrob Agents"},{"key":"2355_CR22","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.abb5883","author":"TP Sheahan","year":"2020","unstructured":"Sheahan TP, Sims AC, Zhou S, Graham RL, Pruijssers AJ, Agostini ML, et al. An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice. Sci Transl Med. 2020. https:\/\/doi.org\/10.1126\/scitranslmed.abb5883.","journal-title":"Sci Transl Med"},{"key":"2355_CR23","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.aohep.2019.09.001","volume":"18","author":"EA Mendes","year":"2019","unstructured":"Mendes EA, Pilger DRB, Santos Nastri ACS, Malta FM, Pascoalino BDS, Carneiro D\u2019Albuquerque LA, et al. Sofosbuvir inhibits yellow fever virus in vitro and in patients with acute liver failure. Ann Hepatol. 2019;18:816\u201324.","journal-title":"Ann Hepatol"},{"key":"2355_CR24","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.antiviral.2018.04.007","volume":"154","author":"W Jiang","year":"2018","unstructured":"Jiang W, Muhammad F, Ma P, Liu X, Long G. Sofosbuvir inhibits hepatitis A virus replication in vitro assessed by a cell-based fluorescent reporter system. Antivir Res. 2018;154:51\u20137.","journal-title":"Antivir Res"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-020-02355-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-020-02355-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-020-02355-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,4]],"date-time":"2021-05-04T23:14:58Z","timestamp":1620170098000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-020-02355-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,5]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2355"],"URL":"https:\/\/doi.org\/10.1186\/s12967-020-02355-3","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,5]]},"assertion":[{"value":"15 April 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"185"}}